HOME >> MEDICINE >> NEWS
HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report

Patients living with HIV who are being treated with protease inhibitors may be less concerned about practicing safe sex than those HIV patients not being treated with the drugs, according to a new collaborative study.

Researchers at Emory University's Rollins School of Public Health, the University of Alabama at Birmingham School of Public Health and the U.S. Centers for Disease Control and Prevention studied sexually active persons living with HIV and found that those treated with protease inhibitors were more likely to report inconsistent condom use compared to persons not treated with protease inhibitors.

Ralph DiClemente, Ph.D., Emory professor of behavioral sciences and health education, will present the research at the American Public Health Association meeting in Washington, D.C. on Nov. 18.

The study included a cross section of persons living with HIV attending six public clinics in non-urban Alabama communities. Within the study group, sexually active patients being treated with protease inhibitors were approximately two and a half times more likely to engage in risky sex (use condoms less than half the time while having sex) compared to patients not being treated with protease inhibitors.

Even more alarming, according to Dr. DiClemente, was the finding that patients using protease inhibitors were also more likely to report "never" using condoms during sexual intercourse. Even after controlling for factors such as age, race, education, and other AIDS defining conditions, patients treated with protease inhibitors were significantly more likely to report engaging in risky sex. There were significant differences, however, by sexual preference.

Within the study group, men who had sex with men (MSM) and were being treated with protease inhibitors were 3.8 times more likely to report condom use less than half the times they engaged in sexual intercourse compared to MSM not being treated with protease inhibitors. MSM using protease inhi
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
18-Nov-1998


Page: 1 2

Related medicine news :

1. Patients newly diagnosed with HIV are more likely to enter outpatient care with case management
2. Patients with cancer have highly increased risk for blood clots
3. Patients with previous heart attacks may not benefit from pacemaker implant
4. Patients with cancer detected on screening mammography undergo less toxic treatment
5. Patients with moderate or severe hand dermatitis responsive to drug therapy
6. Patients with abdominal trauma at risk for intra-abdominal infections following surgery
7. Patients who are intubated prior to hospital arrival fare worse find Pitt researchers
8. Patients undergoing weight loss surgery have high rates of H pylori bacteria
9. Patients with chronic sinus do not necessarily develop antibiotic resistance
10. Plastic surgeons honor Patients of Courage overcoming difficult obstacles, inspiring others
11. Patients with severe depression improve using guidelines developed by UT Southwestern researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... , ... August 31, 2018 , ... ... | 2018" list. , This list includes independent community hospitals as well as ... others care for small communities outside of large cities. The hospitals continue to ...
(Date:8/31/2018)... ... 2018 , ... Kessler Foundation, a major center for rehabilitation ... In the MRI Simulator, the individual experiences the conditions of an actual magnetic ... research participants become accustomed to the sights and sounds of the actual scan, ...
(Date:8/31/2018)... ... August 31, 2018 , ... The ... Heart Association (AHA) to be responsive for procurement purposes. , A 100 million ... now reap the benefits. Companies like Pacific Medical Training are already offering VA ...
(Date:8/31/2018)... TIRANA, Albania (PRWEB) , ... August 31, 2018 ... ... announces research results based on the impact of a biofield energy treated nutraceutical ... preclinical research assessed biomarkers for immune function and blood, as well as, inflammation. ...
(Date:8/31/2018)... ... 2018 , ... Saturday, September 1st, 2018, Team Fastrax™ will perform their fan ... opener game. At 7pm, the Cyclones will kick off against the South Dakota State ... Fastrax™ will jump in with their majestic 2,000 sq. ft. American Flag, red white ...
Breaking Medicine News(10 mins):
(Date:9/12/2018)... COLUMBUS, Ohio (PRWEB) , ... September 13, 2018 , ... ... fastest growing companies, as well as Columbus Business First's Fast 50 list of central ... national list with a 3-year growth rate of 81 percent. It is the only ...
(Date:9/7/2018)... , ... September 07, 2018 , ... ... her new book “Diagnosis: Cancer”: a gripping narrative that shows the author’s experience ... in Africa. , Author Uonelli writes an eventful life that revolves around a ...
(Date:9/3/2018)... ... September 03, 2018 , ... According to ACGME, the state ... residents and 200 fellows for the 2018-2019 academic year. The 64 specialty programs ... institutions such as McLeod Health, MUSC Health, Tidelands Health and Tenet Healthcare will ...
Breaking Medicine Technology:
Cached News: